Jubilant Pharmova Ltd

NSE: JUBLPHARMA · BSE: 530019 · Pharmaceuticals & Biotechnology · 40 announcements

Share price: ₹987.50
Market cap: ₹15,729 Cr
Revenue (annual): ₹8,280 Cr
Net profit (annual): ₹398.5 Cr
P/E (TTM): 44.7×Sector 43.8×
Promoter holding: 47.68%+0.00% QoQ
FII holding: 15.37%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

8 Oct 2026 21:23 IST BSE

Jubilant Pharmova Capacity Expansion: ₹633.1 Cr Investment

Jubilant Pharmova's Radiopharma business will invest CAD 94.5 million (approx. ₹633 Crore) to expand production capacity at its Kirkland facility, aiming to double RUBY-FILL® production.

Value: ₹633.1 Cr
production capacity: 2.0 times

Open announcement → Read the filing ↗

Jubilant Pharmova Ltd by type

Legal & Regulatory 6
Annual General Meeting 5
Other Announcement 5
Business Update 3
Board Meeting Date 3
Financial Results 3
Board Meeting Outcome 3
Debt & Borrowing 2
Credit Rating 2
Results Update 2